Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Deloitte
Julphar
AstraZeneca
Colorcon
UBS
Dow
Fish and Richardson
Chinese Patent Office

Generated: August 17, 2018

DrugPatentWatch Database Preview

Aralez Pharms Company Profile

« Back to Dashboard

Summary for Aralez Pharms
International Patents:195
US Patents:12
Tradenames:4
Ingredients:4
NDAs:4

Drugs and US Patents for Aralez Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aralez Pharms YOSPRALA aspirin; omeprazole TABLET, DELAYED RELEASE;ORAL 205103-002 Sep 14, 2016 DISCN Yes No 9,364,439 ➤ Try a Free Trial Y ➤ Try a Free Trial
Aralez Pharms ZONTIVITY vorapaxar sulfate TABLET;ORAL 204886-001 May 8, 2014 RX Yes Yes 7,235,567 ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Aralez Pharms YOSPRALA aspirin; omeprazole TABLET, DELAYED RELEASE;ORAL 205103-001 Sep 14, 2016 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Aralez Pharms Inc FIBRICOR fenofibric acid TABLET;ORAL 022418-001 Aug 14, 2009 RX Yes No 7,741,373 ➤ Try a Free Trial ➤ Try a Free Trial
Aralez Pharms Inc FIBRICOR fenofibric acid TABLET;ORAL 022418-002 Aug 14, 2009 RX Yes Yes 7,741,373 ➤ Try a Free Trial ➤ Try a Free Trial
Aralez Pharms ZONTIVITY vorapaxar sulfate TABLET;ORAL 204886-001 May 8, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Aralez Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Aralez Pharms TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-003 Jan 10, 1992 5,246,714*PED ➤ Try a Free Trial
Aralez Pharms TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-001 Jan 10, 1992 3,876,802 ➤ Try a Free Trial
Aralez Pharms TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-003 Jan 10, 1992 4,957,745*PED ➤ Try a Free Trial
Aralez Pharms TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-002 Jan 10, 1992 5,246,714*PED ➤ Try a Free Trial
Aralez Pharms TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-002 Jan 10, 1992 4,927,640*PED ➤ Try a Free Trial
Aralez Pharms TOPROL-XL metoprolol succinate TABLET, EXTENDED RELEASE;ORAL 019962-004 Feb 5, 2001 4,927,640*PED ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ARALEZ PHARMS drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 81 mg/40 mg ➤ Subscribe 2016-10-14

Non-Orange Book US Patents for Aralez Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,198,888 Pharmaceutical compositions for the coordinated delivery of NSAIDs ➤ Try a Free Trial
8,557,285 Pharmaceutical compositions for the coordinated delivery of NSAIDs ➤ Try a Free Trial
7,488,742 Thrombin receptor antagonists ➤ Try a Free Trial
9,220,698 Method for delivering a pharmaceutical composition to patient in need thereof ➤ Try a Free Trial
9,801,824 Method for delivering a pharmaceutical composition to patient in need thereof ➤ Try a Free Trial
8,858,996 Pharmaceutical compositions for the coordinated delivery of NSAIDS ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Aralez Pharms Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1411900/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: ESOMEPRAZOL + NAPROXEN; REGISTRATION NO/DATE: SWISSMEDIC 61330 06.05.2011
2015027,C1495018 Lithuania ➤ Try a Free Trial PRODUCT NAME: VORAPAKSARAS; REGISTRATION NO/DATE: EU/1/14/976/001 - EU/1/14/976/006 20150119
2012 00036 Denmark ➤ Try a Free Trial
15/035 Ireland ➤ Try a Free Trial PRODUCT NAME: VORAPAXAR, OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
00746 Netherlands ➤ Try a Free Trial PRODUCT NAME: VORAPAXAR IN ELKE DOOR HET; REGISTRATION NO/DATE: EU/1/14/976/001-006 20150119
00481 Netherlands ➤ Try a Free Trial PRODUCT NAME: NAPROXEN EN ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17901/0263-001 20101105
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
Cantor Fitzgerald
US Department of Justice
Daiichi Sankyo
Fuji
QuintilesIMS
Cipla
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.